CHARLOTTETOWN, PRINCE EDWARD ISLAND, November 17th, 2023 – Today BIOVECTRA celebrates the completion of its $90 million plus biologics expansion at the company’s new state-of-the-art Biomanufacturing Centre with project partners the Government of Canada and Government of Prince Edward Island. “This expansion places BIOVECTRA at the forefront of supporting the next generation of treatments for today’s […]
BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing
